Two patients are referred on the same day to the same orthopaedic surgeon at a Dublin public hospital, each with a worn-out hip. One waits well over a year just for an outpatient appointment. The other sees the consultant within a fortnight and is operated on in the same theatre, by the same surgeon, with the same prosthesis. The difference between them is not clinical. It is a private health insurance policy.

Ireland is an outlier among high-income European countries. It spends generously on health, yet it remains one of the few Western European systems without universal coverage for primary care. Close to half its population buys private insurance, largely to get faster access to a system they already fund through taxation. Most mixed systems keep public and private delivery at least partly separate. For decades, Ireland layered them on top of each other inside the same buildings, staffed by the same clinicians.

That makes Ireland an unusually clean natural experiment. When the care is the same and only the queue differs, we can see exactly what private insurance buys, and what that purchase costs everyone else. Ireland is also a test case for reform. The cross-party Sláintecare plan promised to unwind this arrangement, and both its progress and its stalls hold lessons for any country trying to dismantle entrenched incentives.

One Consultant, Two Payment Models

Irish public hospital consultants have long been allowed to treat private patients alongside public ones, often in the same hospital. The 2008 consultant contract formalised this into categories. Type A contracts were public-only. Type B contracts allowed private practice on-site. Type B* and Type C contracts also permitted work in off-site private rooms. The governing principle was a ratio: private activity was not supposed to exceed roughly 20 percent of a consultant's public hospital workload.

In practice, the ratio proved hard to monitor and harder to enforce. Hospital data repeatedly showed consultants exceeding their permitted private share, sometimes by wide margins. Enforcement was weak partly because hospitals benefited too. After the Health (Amendment) Act 2013, public hospitals could charge insurers for private patients even when those patients occupied public beds. Designating a patient as private became a revenue strategy, and hospitals came to depend on that income.

The result was a dual incentive structure inside a single clinician. Public work was salaried. Private work earned additional fee-for-service income. Economic theory predicts that effort drifts toward the margin that pays, and this does not require bad faith. It happens through ordinary decisions about when clinics run, how theatre lists are filled, and whose follow-up gets priority. A long public waiting list also becomes, in effect, the private practice's best marketing.

The Public Only Consultant Contract, introduced in 2023, marked a decisive break. New consultants in public hospitals now do public work only, in exchange for a substantially higher salary and rostering that extends into evenings and weekends. Existing consultants could opt in, and a significant number have. But a large cohort remains on legacy contracts, so the dual model will wind down over a generation of careers rather than end overnight.

Other systems show how distinctive Ireland's model was. In England, NHS consultants may practise privately, but mostly in separate private hospitals and outside their contracted NHS sessions. France allows activité libérale inside public hospitals, also capped at roughly a fifth of working time, and it attracts similar criticism. Nordic systems largely employ hospital doctors on public-only terms. What set Ireland apart was how completely the two tiers were co-located: same clinics, same theatres, same beds.

Takeaway

When one professional is paid two different ways for the same work, the queue ends up shaped by the payment structure rather than by anyone's intentions.

Buying Time, Not Better Care

In many tiered systems, private insurance buys something visibly different: different providers, nicer facilities, broader choice. The Irish arrangement mostly buys time. The surgery is substantially the same. Survey and administrative evidence consistently shows that insured patients reach specialists and diagnostics faster. The premium is less a payment for care than a payment for position in a queue.

The key mechanism is the outpatient bottleneck. Public patients referred by a GP join outpatient waiting lists that have run into the hundreds of thousands, with many waiting more than a year. An insured patient can see the same consultant in private rooms within weeks and then go straight onto an inpatient or day-case list. They skip the stage where public waits are longest. Faster private access to MRI and other diagnostics shortens the path further.

Primary care compounds the gap. Roughly a third of residents hold a means-tested medical card that covers GP visits. Most others pay out of pocket, often €60 or more per consultation. People who earn too much for a card but cannot comfortably afford insurance pay at the GP's door and then wait in the hospital queue. Cost at the point of entry delays referrals, so disadvantage builds up before the hospital wait even begins.

Within the insured pool, Ireland's market is fairly solidaristic. Community rating, lifetime community rating and risk equalisation stop insurers from pricing by individual health risk, and premiums attract tax relief. But that solidarity ends at the edge of the pool. Take-up rises with income. Many lower-income households buy basic plans as a distress purchase, cutting other spending out of fear of public waits.

The system also reinforces itself. Long public waits drive demand for insurance. Insurance revenue sustains private activity in public hospitals. That activity absorbs consultant capacity that could shorten public waits. The state has even created the National Treatment Purchase Fund to buy private capacity for long-waiting public patients, sometimes paying the same clinicians to clear queues their own dual practice helps create. An insured, politically engaged middle class has less personal stake in fixing the public list.

Takeaway

When capacity is fixed, insurance that buys speed rather than better care buys a place in line, and every place gained is a place someone else loses.

Sláintecare and the Problem of Sequencing

In 2017, the Oireachtas Committee on the Future of Healthcare published the Sláintecare report, a rare cross-party plan for a universal, single-tier system with access based on need rather than ability to pay. Its ten-year agenda included expanding entitlement to free GP and hospital care, shifting care into the community, integrating governance at regional level, and removing private practice from public hospitals.

There has been real progress. Free GP care now covers young children, and GP visit card eligibility has been widened. Public inpatient charges were abolished in 2023. The public-only consultant contract became a reality. Six HSE Health Regions began operating in 2024, bringing hospital and community services together under shared geographic governance. Dedicated elective hospitals, planned for Cork, Galway and Dublin, aim to protect scheduled surgery from emergency pressures.

Implementation has been turbulent, though. In 2021, both the executive director of the Sláintecare programme and the chair of its advisory council resigned, citing concerns about the pace and commitment behind reform. The transitional funding the original plan required has never been reliably ringfenced. Underneath sit hard capacity constraints: hospital bed occupancy among the highest in the OECD, persistent workforce shortages, and steady emigration of trained doctors and nurses.

The deeper challenge is sequencing. Remove private practice before public capacity grows, and waits may simply lengthen for everyone, while private work migrates to standalone private hospitals. That would rebuild two tiers in separate buildings. Expand free entitlement before capacity exists, and the surge in demand overwhelms supply. The 2019 de Buitléir review recommended phasing out private practice over roughly a decade, with compensation for lost hospital income, because a single abrupt step would fail.

Ireland has also struggled to settle on a financing model. An earlier plan for Dutch-style universal health insurance was shelved in 2015 after costings suggested it would raise expenditure. Sláintecare leaves the long-term role of private insurance largely unresolved. Australia offers one alternative: a universal public floor with a parallel private tier openly tolerated. The Netherlands offers another: a single tier delivered through regulated competing insurers. Ireland's reform so far reads more as a direction of travel than a finished blueprint.

Takeaway

Dismantling a two-tier system depends less on abolishing the private tier than on building enough public capacity that the private queue stops being worth paying for.

Ireland shows something that blended systems elsewhere can obscure. When the same clinician, theatre and bed serve both tiers, private insurance turns out to buy priority, not quality. Making that visible is uncomfortable, but it is also clarifying.

Several design lessons travel well beyond Ireland. Dual payment structures inside a single professional will reshape queues whatever the stated ratios say. Cost barriers at the primary care door amplify inequities downstream. And reforms that remove privileges before expanding capacity risk making the shared queue longer rather than fairer.

Sláintecare's slow, uneven progress is not unusual. Most major health system reforms take a generation, and they usually advance through contracts, governance and capacity rather than declarations. Whether Ireland reaches a single tier may depend less on political will in any single year than on whether it keeps building the public capacity that makes paying for a better place in line unnecessary.